Low IL-13Rα1 expression on mast cells tunes them unresponsive to IL-13
Open Access
- 24 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 114 (2) , 187-194
Abstract
Cytokine-mediated mast cell regulation enables precise optimization of their own proinflammatory cytokine production. During allergic inflammation, interleukin (IL)-4 regulates mast cell functions, tissue homing, and proliferation, but the direct role of closely related IL-13 for mast cell activation remains unclear. Previous work has shown that mast cells are potent IL-13 producers, but here we show that mouse mast cells do not directly respond to IL-13 by Stat6 activation, as they do not express measurable amount of IL-13 receptor α1 (IL-4Rα1) messenger RNA. Consequently, IL-4 responses are mediated via type I IL-4R (IL-4/IL4Rα/γC), and IL-4–induced Stat6 activation is abolished in γC-deficient mast cells. Type II IL-4R deficiency (IL-13Rα1 knockout) has no effect on IL-4–induced Stat6 activation. In basophils, both IL-4 and IL-13 induce Stat6 activation in wild-type and γC-deficient cells, while in type II IL-4R–deficient basophils, IL-4 signaling is impaired at low ligand concentration. Thus, mast cell and basophil sensitivity to IL-4/IL-13 is different, and in mast cells, lack of IL-13Rα1 expression likely explains their unresponsiveness to IL-13.Keywords
Funding Information
- Research Council of Finland (25013080481, 25013142041, 25013142041, 287907)
- Competitive State Research Financing of the Expert Responsibility area of Fimlab Laboratories (X51409)
- Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9X011, 9V010)
- Tampere University Hospital Support Foundation (MK247, T.A.H.J.)
- Tampere Tuberculosis Foundation
- Paivikki and Sakari Sohlberg Foundation
- T.A.H.J.
- Orion Research Foundation
- Allergy Research Foundation
- Nordlab Laboratories (X3710-KT0011)
This publication has 27 references indexed in Scilit:
- Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3Journal of Allergy and Clinical Immunology, 2013
- Transcriptional regulation by STAT6Immunologic Research, 2011
- Mast Cell Biology: Introduction and Overview2011
- Differentiation of Effector CD4 T Cell PopulationsAnnual Review of Immunology, 2010
- Interleukin‐13 promoter gene polymorphism ‐1112C/T is associated with the systemic form of mastocytosisAllergy, 2009
- Type I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in MacrophagesScience Signaling, 2008
- Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Rα, IL-13Rα1, and γc regulates relative cytokine sensitivityJournal of Experimental Medicine, 2008
- Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 SystemCell, 2008
- Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chainNature Immunology, 2007
- B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cellsCell, 1987